|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU759641B2
(en)
|
1998-08-19 |
2003-04-17 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル，リミティド |
血管新生抑制剤のナノ粒子組成物
|
|
US20040171691A1
(en)
*
|
2002-10-29 |
2004-09-02 |
Transform Pharmaceuticals, Inc. |
Propofol with cysteine
|
|
HUE040046T2
(hu)
*
|
2002-12-09 |
2019-02-28 |
Abraxis Bioscience Llc |
Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
|
|
US7468394B1
(en)
*
|
2003-03-11 |
2008-12-23 |
Amphastar Pharmaceuticals, Inc. |
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
|
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
US8546453B2
(en)
*
|
2003-08-14 |
2013-10-01 |
Rensheng Zhang |
Propofol compositions and methods for reducing pain associated with propofol injection
|
|
RU2290169C1
(ru)
*
|
2005-06-23 |
2006-12-27 |
Открытое Акционерное Общество "Фаберлик" |
Косметическое и/или дерматологическое средство и антиоксидант
|
|
JP5368093B2
(ja)
*
|
2005-08-31 |
2013-12-18 |
アブラクシス バイオサイエンス， エルエルシー |
増大した安定性を有する難水溶性薬剤の組成物および調製の方法
|
|
TR200801337T1
(tr)
*
|
2005-08-31 |
2008-07-21 |
Abraxis Bioscience, Llc. |
Suda zayıf çözülebilen farmasötik ajanlar ve antimikrobiyal ajanlar içeren kompozisyonlar.
|
|
CN101411685B
(zh)
*
|
2007-10-19 |
2011-04-20 |
上海医药工业研究院 |
一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
|
|
KR101656121B1
(ko)
|
2010-03-17 |
2016-09-08 |
노바리크 게엠베하 |
안압 증가를 치료하기 위한 약학 조성물
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
BR112013016661B1
(pt)
*
|
2011-01-04 |
2021-08-03 |
Novaliq Gmbh |
Emulsões de o/a compreendendo alcanos semifluorados
|
|
JP6027549B2
(ja)
|
2011-03-04 |
2016-11-16 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールを含む半固形の水性医薬組成物
|
|
EA028149B1
(ru)
*
|
2011-03-04 |
2017-10-31 |
Грюненталь Гмбх |
Парентеральное введение тапентадола
|
|
LT2680832T
(lt)
|
2011-03-04 |
2019-10-25 |
Gruenenthal Gmbh |
Tapentadolio vandeninė farmacinė kompozicija, skirta vartoti geriant
|
|
JP2019142972A
(ja)
*
|
2011-03-04 |
2019-08-29 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールの非経口的投与
|
|
EP3311802B1
(en)
|
2011-05-25 |
2023-11-01 |
Dermaliq Therapeutics, Inc. |
Topical pharmaceutical composition based on semifluorinated alkanes
|
|
JP2013001700A
(ja)
*
|
2011-06-21 |
2013-01-07 |
Fujifilm Corp |
プロポフォール含有水中油型エマルション組成物
|
|
JP5759804B2
(ja)
*
|
2011-06-27 |
2015-08-05 |
富士フイルム株式会社 |
容器詰製剤
|
|
MX361681B
(es)
|
2012-01-23 |
2018-12-13 |
Novaliq Gmbh |
Composiciones de proteína estabilizadas basadas en alcanos semifluorados.
|
|
WO2013172999A1
(en)
|
2012-05-16 |
2013-11-21 |
Mewa Singh |
Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
|
|
EP3100722B1
(en)
|
2012-09-12 |
2024-03-20 |
Novaliq GmbH |
Semifluorinated alkanes for use in solubilizing meibum
|
|
DK2895144T3
(en)
|
2012-09-12 |
2017-03-06 |
Novaliq Gmbh |
SEMIFLUORED ALKAN COMPOSITIONS
|
|
US10273298B2
(en)
|
2013-07-23 |
2019-04-30 |
Novaliq Gmbh |
Stabilized antibody compositions
|
|
JP6923447B2
(ja)
|
2015-03-27 |
2021-08-18 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールの非経口投与のための安定な製剤
|
|
WO2017017693A1
(en)
*
|
2015-07-24 |
2017-02-02 |
Neon Laboratories Limited |
Stabilized injectable emulsion of propofol and ketamine
|
|
WO2017031261A1
(en)
|
2015-08-20 |
2017-02-23 |
Mewa Singh |
Polyphenolic polymer to make water-insoluble molecules become water-soluble
|
|
US11154513B2
(en)
|
2015-09-30 |
2021-10-26 |
Novaliq Gmbh |
Semifluorinated compounds
|
|
US20170087100A1
(en)
|
2015-09-30 |
2017-03-30 |
Novaliq Gmbh |
Semifluorinated compounds and their compositions
|
|
JP2019520357A
(ja)
|
2016-06-23 |
2019-07-18 |
ノバリック ゲーエムベーハー |
局所投与方法
|
|
JP7012075B2
(ja)
|
2016-09-22 |
2022-01-27 |
ノバリック ゲーエムベーハー |
眼瞼炎の治療に使用するための医薬組成物
|
|
EP3515412B1
(en)
|
2016-09-23 |
2025-04-23 |
Grünenthal GmbH |
Stable formulation for parenteral administration of tapentadol
|
|
JP6869336B2
(ja)
|
2016-09-23 |
2021-05-12 |
ノバリック ゲーエムベーハー |
シクロスポリンを含む眼科用組成物
|
|
PT3399962T
(pt)
|
2016-12-23 |
2020-09-03 |
Novaliq Gmbh |
Composição oftálmica para o tratamento da doença do olho seco
|
|
ES2957559T3
(es)
|
2017-04-21 |
2024-01-22 |
Dermaliq Therapeutics Inc |
Composiciones de yodo
|
|
WO2018206656A1
(en)
|
2017-05-12 |
2018-11-15 |
Novaliq Gmbh |
Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
KR20200059272A
(ko)
|
2017-09-27 |
2020-05-28 |
노바리크 게엠베하 |
안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물
|
|
US11896559B2
(en)
|
2017-10-04 |
2024-02-13 |
Novaliq Gmbh |
Opthalmic compositions comprising F6H8
|
|
JP7353292B2
(ja)
|
2018-03-02 |
2023-09-29 |
ノバリック ゲーエムベーハー |
ネビボロールを含む医薬組成物
|
|
US12226422B2
(en)
|
2018-04-27 |
2025-02-18 |
Novaliq Gmbh |
Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
|
|
CA3112031A1
(en)
|
2018-10-12 |
2020-04-16 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
US12397039B2
(en)
|
2019-02-13 |
2025-08-26 |
Novaliq Gmbh |
Compositions and methods for the treatment of ocular neovascularization
|